Is hormonal treatment still an option in acne today?

What's new in the physiopathology of acne?

(2015) D.H. Suh et al.   BRITISH JOURNAL OF DERMATOLOGY

Transcriptional control of local estrogen formation by aromatase in the breast

(2015) Sarah Q. To et al.   JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY

Polycystic ovary syndrome: Metabolic consequences and long-term management

(2014) Enrico Carmina   SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION

17-Hydroxyprogesterone in children, adolescents and adults

(2014) John W Honour   ANNALS OF CLINICAL BIOCHEMISTRY

Profiling and hormonal therapy for acne in women

(2014) Sangita Ghosh et al.   INDIAN JOURNAL OF DERMATOLOGY

Hormone therapy in acne

(2013) Chembolli Lakshmi   Indian Journal of Dermatology Venereology & Leprology

Cushing Syndrome

(2013) Bibek Bista et al.   INDIAN JOURNAL OF PEDIATRICS

Contraception and the dermatologist

(2013) Kelly H. Tyler et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

European Commission orders France to lift ban on acne pill

(2013) S. Arie   BMJ-British Medical Journal

The role of androgen and androgen receptor in skin-related disorders

(2012) Jiann-Jyh Lai et al.   ARCHIVES OF DERMATOLOGICAL RESEARCH

Hormonal contraceptives and venous thromboembolism: An epidemiological update

(2012) Genevieve Plu-Bureau et al.   BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM

Efficacy and tolerability of a monophasic combined oral contraceptive containing nomegestrol acetate and 17β-oestradiol in a 24/4 regimen, in comparison to an oral contraceptive containing ethinylestradiol and drospirenone in a 21/7 regimen

(2012) Diana Mansour et al.   EUROPEAN JOURNAL OF CONTRACEPTION AND REPRODUCTIVE HEALTH CARE

European Evidence-based (S3) Guidelines for the Treatment of Acne

(2012) A. Nast et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Effects of Oral Contraceptives Containing Ethinylestradiol with Either Drospirenone or Levonorgestrel on Various Parameters Associated with Well-Being in Healthy Women

(2010) Sue Kelly et al.   CLINICAL DRUG INVESTIGATION

Retrospective, observational study on the effects and tolerability of flutamide in a large population of patients with acne and seborrhea over a 15-year period

(2010) Roberto Paradisi et al.   GYNECOLOGICAL ENDOCRINOLOGY

Hormonelle Antiandrogene in der Aknetherapie

(2010) Christos C. Zouboulis et al.   JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT

Hormone therapy for acne

(2010) Jacqueline M. Junkins-Hopkins   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Lipid Mediators in Acne

(2010) Monica Ottaviani et al.   MEDIATORS OF INFLAMMATION

Treatment of Acne Using a 3-Milligram Drospirenone/20-Microgram Ethinyl Estradiol Oral Contraceptive Administered in a 24/4 Regimen

(2010) J Michael Maloney et al.   OBSTETRICS AND GYNECOLOGY

Hormonal therapy for acne: why not as first line therapy? facts and controversies

(2009) Andreas D. Katsambas et al.   CLINICS IN DERMATOLOGY

Efficacy of an oral contraceptive containing EE 0.03 mg and CMA 2 mg (Belara®) in moderate acne resolution: a randomized, double-blind, placebo-controlled Phase III trial

(2009) Gerd Plewig et al.   CONTRACEPTION

Experience in the long-term treatment of patients with hirsutism and/or acne with cyproterone acetate-containing preparations: Efficacy, metabolic and endocrine effects

(2009) R. G. A. van Wayjen et al.   EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES

New insights into the management of acne: An update from the Global Alliance to Improve Outcomes in Acne Group

(2009) Diane Thiboutot et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Acne and Systemic Disease

(2009) Margarita S. Lolis et al.   MEDICAL CLINICS OF NORTH AMERICA

Accumulation of lipid peroxide in the content of comedones may be involved in the progression of comedogenesis and inflammatory changes in comedones

(2009) Takumi Tochio et al.   Journal of Cosmetic Dermatology

Efficacy of a combined oral contraceptive containing 0.030 mg ethinylestradiol/2 mg dienogest for the treatment of papulopustular acne in comparison with placebo and 0.035 mg ethinylestradiol/2 mg cyproterone acetate

(2008) Ernesta Palombo-Kinne et al.   CONTRACEPTION

Hormonal Therapy for Acne

(2008) Rosalyn George et al.   SEMINARS IN CUTANEOUS MEDICINE AND SURGERY

Efficacy and tolerance of acne treatment using both spironolactone and a combined contraceptive containing drospirenone

(2007) Aleksandar Krunic et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY